501121-63-7

Upstream product

• 501121-57-9 2-(1-benzyl-2-(phenylsulfanyl)ethyl)isoindole-1,3-dione 
• 882-33-7 diphenyldisulfane 
• 70451-01-3 (-)-(S)-2-(1-benzyl-2-hydroxyethyl)-1H-isoindole-1,3(2H)-dione 
• 501121-60-4 2-(1-benzyl-2-fluoro-2-phenylsulfanyl-ethyl)-isoindole-1,3-dione 

Downstream Products

• 851977-08-7 N-(1-benzyl-2-fluoro-2-phenylsulfanyl-ethyl)-2-[2-(1,3-dioxo-1,3-dihydro-isoindol-2-yl)acetylamino]-3-methyl-butyramide 
• 851976-94-8 1-{1-[(1-benzyl-2-fluoro-2-phenylsulfanyl-ethyl-amino)-methyl]-2-methyl-propylamino}-2-{[(9H-fluoren-9-ylmethoxy)-hydroxymethyl]-amino}-ethanol 
• 851976-57-3 (S)-2-(2-Amino-acetylamino)-N-((S)-1-benzyl-2-fluoro-2-phenylsulfanyl-ethyl)-3-methyl-butyramide 
• 851976-67-5 2-amino-1-{1-[(1-benzyl-2-fluoro-2-phenylsulfanyl-ethyl-amino)-methyl]-2-methyl-propylamino}-ethanol 
• 851976-93-7 N¹-(1-benzyl-2-fluoro-2-phenylsulfanyl-ethyl)-3-methyl-butane-1,2-diamine 

Relevant academic research and scientific papers

Novel fluoropeptidomimetics: Synthesis, stability studies and protease inhibition

Designer fluoropeptidomimetics as protease inhibitors are revealed. The key peptidomimetic region in the inhibitors contains a '-CHF-S-' moiety and is designed to mimic the tetrahedral oxyanion species during the hydrolysis of a peptide bond. Designed flu

Design and synthesis of novel fluoropeptidomimetics as potential mimics of the transition state during peptide hydrolysis

α-Fluoroamino acids were targeted in our ongoing efforts to design novel fluoropeptidomimetics (1) as potential protease inhibitors. α-Fluoroglycine derivative (2) and α-fluoro-β-aminoethanethiol derivatives (3-9) were synthesized for the first time en ro